At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
6 の 4 を表示する
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
An indispensable part of the ConsiGma 4.0 portfolio, the Conductor 4.0 control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.
Coffee, cocoa, milk, meat, fish and eggs – these daily staples rely heavily on intensive agriculture. With the rise of new food technologies, we have more sustainable alternatives. We sat down with Dr. Reimar Gutte, Senior Vice...
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology...
GEA製品販売部長のパトリック・シュールマンにとって、レシチンは特別な存在です。当初は食用油の精製において脇役にすぎなかったものの、何にでも使える物質として、競争が激しく利益率の低い食用油精製市場で見事に主役の座を獲得。実はこれ、シュールマンが同僚と一緒に開発した、革新的で省エネな新製法によるところが大きいのです。